At a glance
- Originator Celgene Corporation
- Class Antiasthmatics; Phthalimides; Small molecules
- Mechanism of Action Type 4 cyclic nucleotide phosphodiesterase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Aphthous stomatitis; Asthma; Cachexia; HIV-1 infections